跳至主要内容
临床试验/NCT05590936
NCT05590936已完成不适用

Comparison of the Effectiveness of Dimenydrinate vs Ondasetron on the Prevention of Postoperative Nausea and Vomiting

University of Thessaly1 个研究点 分布在 1 个国家目标入组 190 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
190
试验地点
1
主要终点
PONV

研究概览

简要总结

This study will investigate the impact of dimenydrinate (H1-receptor antagonist) versus ondansetron (HT3-receptor antagonist) in postoperative nausea and vomiting, in surgery-related preoperative stress and in the incidence of postoperative complications that could lengthen the LOS in PACU and/or the overall LOS.

详细描述

Dimenydrinate has been extensively used for motion sickness. However, as far as postoperative nausea and vomiting is concerned the results are still conflicting.

This study will investigate the impact of dimenydrinate (H1-receptor antagonist) versus ondansetron (HT3-receptor antagonist) in postoperative nausea and vomiting, in surgery-related preoperative stress and in the incidence of postoperative complications that could lengthen the LOS in PACU and/or the overall LOS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-75 years old
  • ASA PS I-III
  • Undergoing laparoscopic general surgery operations or laparoscopic gynecological operations

排除标准

  • Refused to participate
  • Age other than 18-75 years old
  • Pregnant patients
  • Non-elective operations
  • Patients that are not able to receive p.os agents
  • Medical history of Brugada Sdr or Brugada-like/related ECG abnormalities
  • Long-Qt Sdr or concurrent use of medications that may cause long-QT ECG abnormalities
  • Medical or family history of psychosis
  • Allergy in dimenydrinate or in dimenydrinate drug versions
  • Perioperative use of dexamethasone

研究组 & 干预措施

Dimenydrinate

Active Comparator

Preoperative per os administration of 50 mg dimenydrinate

干预措施: Dimenhydrinate Tablets (Drug)

Ondasentron

Other

Intraoperative intravenous administration of 4 mg ondansetron

干预措施: Ondansetron iv (Drug)

结局指标

主要结局

PONV

时间窗: 24 hours postoperative

PONV recording in patients undergone laparoscopic cholocystectomy

次要结局

  • preoperative anxiety(30 minutes before operation)
  • Awaken time(on extubation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elena Arnaoutoglou

Professor of anesthesiology

University of Thessaly

研究点 (1)

Loading locations...

相似试验